Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2020-07-29
DOI
10.1080/17425255.2020.1803277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OPTN / SRTR 2018 Annual Data Report: Kidney
- (2020) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
- (2020) Natalia Lucía Rukavina Mikusic et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation
- (2020) Edouard Bonneville et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients
- (2020) Camille Tron et al. PLoS One
- Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation
- (2020) Douglas L. Jennings et al. PLoS One
- Clinical Implications of Unique Drug Interaction Between Extended Release Tacrolimus and Phenytoin
- (2020) Taylor M. Harkness et al. Progress in Transplantation
- Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19)
- (2020) Marilù Bartiromo et al. Transplant Infectious Disease
- Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant
- (2020) Ibtissem Hannachi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites
- (2019) Yukuang Guo et al. DRUG METABOLISM AND DISPOSITION
- Prior Amiodarone Exposure Reduces Tacrolimus Dosing Requirements in Heart Transplant Recipients
- (2019) Nadine T. Breslin et al. Progress in Transplantation
- Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient
- (2019) Calvin J. Meaney et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients
- (2019) Zheng Lu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients
- (2019) Paolo Gallo et al. European Journal of Internal Medicine
- Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once‐daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation
- (2019) Akira Mimura et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Marked change in blood tacrolimus concentration levels due to grapefruit in a renal transplant patient
- (2019) Xingyu Zhai et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy
- (2019) Mercè Brunet et al. THERAPEUTIC DRUG MONITORING
- Impact of CYP3A5 Genetic Polymorphism on Intrapatient Variability of Tacrolimus Exposure in Chinese Kidney Transplant Recipients
- (2019) Chi Yuen Cheung et al. TRANSPLANTATION PROCEEDINGS
- Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients
- (2019) Amelia R. Cossart et al. Translational Andrology and Urology
- Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients
- (2019) Aleixandra Mendoza Rojas et al. Expert Review of Clinical Immunology
- Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
- (2018) Babar Bashir et al. CTS-Clinical and Translational Science
- Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
- (2018) Olivia Campagne et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability
- (2018) Litaty Céphanoée Mbatchi et al. PHARMACOGENOMICS
- Detection of a rare CYP3A4 variant in a transplant patient characterized by a tacrolimus poor metabolizer phenotype
- (2018) Nuria Lloberas et al. PHARMACOGENOMICS
- A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation
- (2018) Sandar Min et al. PEDIATRIC TRANSPLANTATION
- Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
- (2018) Nassim Kamar et al. ADVANCES IN THERAPY
- A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients
- (2018) L.M. Andrews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
- (2018) Camille Tron et al. CLINICAL PHARMACOKINETICS
- Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus, and everolimus
- (2018) Rong Wang et al. XENOBIOTICA
- Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation
- (2018) Suda Vannaprasaht et al. International Journal of Clinical Pharmacy
- Kidney Transplant in a Human Immunodeficiency Virus-Positive Patient: Case Report of Drug Interactions
- (2017) Mümtaz Yılmaz et al. Experimental and Clinical Transplantation
- Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients
- (2017) Fei Liu et al. Genetic Testing and Molecular Biomarkers
- Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity
- (2017) Kristyna Krasulova et al. MOLECULES
- Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22?
- (2017) Laure Elens et al. PHARMACOGENOMICS
- Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients
- (2017) W S Oetting et al. PHARMACOGENOMICS JOURNAL
- Tacrolimus: Does direct glucuronidation matter? An analytical and pharmacological perspective
- (2017) Camille Tron et al. PHARMACOLOGICAL RESEARCH
- An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
- (2017) Rebecca M. Pollet et al. STRUCTURE
- Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients
- (2017) Thomas Vanhove et al. THERAPEUTIC DRUG MONITORING
- Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
- (2017) Andreas H. Groll et al. Transplant Infectious Disease
- High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime
- (2017) Henry R. Whalen et al. TRANSPLANTATION
- Tacrolimus Increases the Effectiveness of Itraconazole and Fluconazole against Sporothrix spp.
- (2017) Luana P. Borba-Santos et al. Frontiers in Microbiology
- Interleukin-6 Induces DEC1, Promotes DEC1 Interaction with RXRα and Suppresses the Expression of PXR, CAR and Their Target Genes
- (2017) Rui Ning et al. Frontiers in Pharmacology
- Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
- (2017) Jean-Baptiste Woillard et al. Frontiers in Pharmacology
- Colchicine-Induced Myopathy in a Tacrolimus-Treated Renal Transplant Recipient
- (2016) Zeenat Yousuf Bhat et al. AMERICAN JOURNAL OF THERAPEUTICS
- High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients
- (2016) T. Vanhove et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation
- (2016) N. Shuker et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations
- (2016) J.T. Tang et al. Expert Opinion on Drug Metabolism & Toxicology
- A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients
- (2016) Camille Tron et al. JOURNAL OF CHROMATOGRAPHY A
- Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice
- (2016) Takuya Kuno et al. MOLECULAR PHARMACEUTICS
- The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
- (2016) Peter Spanogiannopoulos et al. NATURE REVIEWS MICROBIOLOGY
- CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing
- (2016) Danxin Wang et al. Pharmacogenetics and Genomics
- Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study
- (2016) Martine De Meyer et al. PHARMACOGENOMICS
- A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform
- (2016) Y Choi et al. PHARMACOGENOMICS JOURNAL
- Kidney Transplant Recipients Carrying theCYP3A4*22Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations
- (2015) N. Pallet et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation
- (2015) Carlos Orlando Jacobo-Cabral et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients
- (2015) Beatriz Tavira et al. JOURNAL OF HUMAN GENETICS
- Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
- (2015) Sarah Leyking et al. Journal of Translational Medicine
- The Functional Implications of Common Genetic Variation in CYP3A5 and ABCB1 in Human Proximal Tubule Cells
- (2015) Noël Knops et al. MOLECULAR PHARMACEUTICS
- African-American Race Modifies the Influence of Tacrolimus Concentrations on Acute Rejection and Toxicity in Kidney Transplant Recipients
- (2015) David J. Taber et al. PHARMACOTHERAPY
- Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus
- (2015) Henrike Bruckmueller et al. THERAPEUTIC DRUG MONITORING
- Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice
- (2015) Felcy Pavithra Selwyn et al. TOXICOLOGICAL SCIENCES
- Advagraf®, a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts
- (2015) Sophie Caillard et al. TRANSPLANT INTERNATIONAL
- A Rationale for Age-Adapted Immunosuppression in Organ Transplantation
- (2015) Felix Krenzien et al. TRANSPLANTATION
- Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation
- (2015) L. Yessayan et al. TRANSPLANTATION PROCEEDINGS
- Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
- (2015) John R. Lee et al. PLoS One
- Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus
- (2014) Anara Amanova et al. CLINICAL TRANSPLANTATION
- The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
- (2014) Ingrid Lunde et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Proton Pump Inhibitor Lansoprazole, but not Rabeprazole, the Increased Blood Concentrations of Calcineurin Inhibitors in Japanese Patients with Connective Tissue Diseases
- (2014) Kentaro Isoda et al. INTERNAL MEDICINE
- Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients
- (2014) Mateusz Kurzawski et al. Pharmacogenetics and Genomics
- Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
- (2014) L Rojas et al. PHARMACOGENOMICS JOURNAL
- The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients
- (2014) H de Jonge et al. PHARMACOGENOMICS JOURNAL
- ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines
- (2014) Géraldine Dessilly et al. PLoS One
- Effects of Elevated Tacrolimus Trough Levels in Association With Infectious Enteritis on Graft Function in Renal Transplant Recipients
- (2014) A. Nakamura et al. TRANSPLANTATION PROCEEDINGS
- Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients
- (2013) Lynda Frassetto et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks
- (2013) Laure Elens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women
- (2013) Flavia Franconi et al. BRITISH JOURNAL OF PHARMACOLOGY
- MDR1 Synonymous Polymorphisms Alter Transporter Specificity and Protein Stability in a Stable Epithelial Monolayer
- (2013) King Leung Fung et al. CANCER RESEARCH
- The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
- (2013) Dennis A. Hesselink et al. CLINICAL PHARMACOKINETICS
- Effect of CYP3A5*3 Polymorphism on Pharmacokinetic Drug Interaction between Tacrolimus and Amlodipine
- (2013) Xiao-cong Zuo et al. Drug Metabolism and Pharmacokinetics
- Importance of hematocrit for a tacrolimus target concentration strategy
- (2013) Elisabet Størset et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Total plasma protein effect on tacrolimus elimination in kidney transplant patients – Population pharmacokinetic approach
- (2013) Bojana Golubović et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients
- (2013) Dan-ying Li et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
- (2013) Ruth Sapir-Pichhadze et al. KIDNEY INTERNATIONAL
- Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation
- (2013) Matthew D. Hickey et al. LIVER TRANSPLANTATION
- Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin
- (2013) Laure Elens et al. Pharmacogenetics and Genomics
- Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation
- (2013) Luis E. Rojas et al. Pharmacogenetics and Genomics
- Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus
- (2013) Laure Elens et al. Pharmacogenetics and Genomics
- Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients
- (2013) Xiao-cong Zuo et al. Pharmacogenetics and Genomics
- CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
- (2013) Laure Elens et al. PHARMACOGENOMICS
- CYP3A4*22andCYP3Acombined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients
- (2013) Violette MGJ Gijsen et al. PHARMACOGENOMICS
- Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
- (2013) H. J. Haiser et al. SCIENCE
- Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal Transplantation
- (2013) Laure Elens et al. THERAPEUTIC DRUG MONITORING
- P450 Oxidoreductase *28 (POR*28) and Tacrolimus Disposition in Pediatric Kidney Transplant Recipients—A Pilot Study
- (2013) Violette M. G. J. Gijsen et al. THERAPEUTIC DRUG MONITORING
- Long-Term Impact of Immunosuppressants at Therapeutic Doses on Male Reproductive System in Unilateral Nephrectomized Rats: A Comparative Study
- (2013) Yehui Chen et al. Biomed Research International
- TheCYP3A4*22allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations
- (2012) Laure Elens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo
- (2012) Kathrin Klein et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation
- (2012) I A Hauser et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
- (2012) Nayoung Han et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients
- (2012) Wei Zhao et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pomegranate-containing products and tacrolimus: A potential interaction
- (2012) Tam Khuu et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation
- (2012) Martine De Meyer et al. JOURNAL OF SURGICAL RESEARCH
- Pharmacogenetics in Kidney Transplantation
- (2012) Laure Elens et al. Molecular Diagnosis & Therapy
- The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients
- (2012) Salvatore Terrazzino et al. Pharmacogenetics and Genomics
- CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy
- (2012) Laure Elens et al. PHARMACOGENOMICS
- Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients
- (2012) Yi Li et al. TRANSPLANT IMMUNOLOGY
- Effect of Mild Diarrhea on Tacrolimus Exposure
- (2012) Gerben A.J. van Boekel et al. TRANSPLANTATION
- Risk of Tacrolimus Toxicity in CYP3A5 Nonexpressors Treated With Intravenous Nicardipine After Kidney Transplantation
- (2012) David K. Hooper et al. TRANSPLANTATION
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
- (2011) J. Sellarés et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers
- (2011) A. J. Wright et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients
- (2011) L. Elens et al. CLINICAL CHEMISTRY
- Age-Related Changes in Pharmacokinetics
- (2011) Shaojun Shi et al. CURRENT DRUG METABOLISM
- A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
- (2011) Flora Tshinanu Musuamba et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient
- (2011) Michelle Maguire et al. PEDIATRIC TRANSPLANTATION
- The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients
- (2011) Kelly A. Birdwell et al. Pharmacogenetics and Genomics
- Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
- (2011) Laure Elens et al. PHARMACOGENOMICS
- The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
- (2011) Hylke de Jonge et al. PHARMACOGENOMICS
- Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
- (2010) Jean-Baptiste Woillard et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation
- (2010) Khaled Benkali et al. CLINICAL PHARMACOKINETICS
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
- (2010) E Thervet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis
- (2010) X.-J. Shi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cytochrome P450-mediated metabolism in the human gut wall
- (2010) Kirstin Thelen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Very important pharmacogene summary
- (2010) Laura M. Hodges et al. Pharmacogenetics and Genomics
- Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients
- (2010) Ping Wang et al. PHARMACOGENOMICS
- CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation
- (2010) Arnaud Capron et al. PHARMACOGENOMICS
- Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective
- (2010) J-L Li et al. PHARMACOGENOMICS JOURNAL
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
- (2010) B. D. Wallace et al. SCIENCE
- Elevated Tacrolimus Levels Associated With Intravenous Azithromycin and Ceftriaxone: A Case Report
- (2010) M.A. Shullo et al. TRANSPLANTATION PROCEEDINGS
- Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
- (2009) Khaled Benkali et al. CLINICAL PHARMACOKINETICS
- Sex Differences in Pharmacokinetics and Pharmacodynamics
- (2009) Offie P. Soldin et al. CLINICAL PHARMACOKINETICS
- Drug Interaction Between Tacrolimus and Carbamazepine in a Japanese Heart Transplant Recipient: A Case Report
- (2009) Kyoichi Wada et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts
- (2009) M. Naesens et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test
- (2009) Beatrice Oneda et al. Pharmacogenetics and Genomics
- Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?
- (2008) S. Lam et al. ANNALS OF PHARMACOTHERAPY
- Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity
- (2008) Andrea DiMartini et al. LIVER TRANSPLANTATION
- CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
- (2008) Dennis A. Hesselink et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now